Published in J Med Genet on July 01, 2003
A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO. J Med Genet (2004) 3.10
Validity of models for predicting BRCA1 and BRCA2 mutations. Ann Intern Med (2007) 1.94
Evaluation of models to predict BRCA germline mutations. Br J Cancer (2006) 1.12
Optimal selection for BRCA1 and BRCA2 mutation testing using a combination of 'easy to apply' probability models. Br J Cancer (2006) 0.81
Establishing a program for individuals at high risk for breast cancer. J Cancer (2013) 0.75
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science (1994) 36.53
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet (1998) 15.09
Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science (1994) 8.73
Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol (2002) 6.69
Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet (1998) 5.95
BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med (1997) 4.33
BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing. JAMA (1997) 2.78
Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. J Natl Cancer Inst (2002) 2.45
Application of breast cancer risk prediction models in clinical practice. J Clin Oncol (2003) 2.19
A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families. Am J Hum Genet (1997) 2.01
A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families. Br J Cancer (2001) 1.44
Interpreting epidemiological research: blinded comparison of methods used to estimate the prevalence of inherited mutations in BRCA1. J Med Genet (2001) 1.26
Genetic testing for cancer predisposition. Annu Rev Med (2001) 1.21
Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families. Br J Cancer (2000) 0.98
Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: implications for genetic testing. Int J Cancer (2002) 0.95
BRCA1-related breast cancer in Austrian breast and ovarian cancer families: specific BRCA1 mutations and pathological characteristics. Int J Cancer (1998) 0.91
BRCA2 mutation analysis of 87 Spanish breast/ovarian cancer families. Ann Oncol (2001) 0.84
BRCA1 mutation analysis in 83 Spanish breast and breast/ovarian cancer families. Int J Cancer (1999) 0.82
Release of secretory products during transient vesicle fusion. Nature (1993) 4.57
The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int (2011) 4.27
Distribution and kinetics of membrane dielectric polarization. 1. Long-term inactivation of gating currents. J Gen Physiol (1982) 3.85
Patterns of polymorphism and linkage disequilibrium for cystic fibrosis. Genomics (1987) 3.03
Is cisplatin-induced cell death always produced by apoptosis? Mol Pharmacol (2001) 2.56
Nature over nurture: temperament, personality, and life span development. J Pers Soc Psychol (2000) 2.38
A frame-shift deletion in the survival motor neuron gene in Spanish spinal muscular atrophy patients. Nat Genet (1995) 2.24
A simple device for marking the areola in Lejour's mammaplasty. Plast Reconstr Surg (1998) 2.22
Long-term outcome of patients with asystole induced by head-up tilt test. Eur Heart J (2002) 2.21
Distribution and kinetics of membrane dielectric polarization. II. Frequency domain studies of gating currents. J Gen Physiol (1982) 2.09
Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables. Ann Oncol (2008) 2.06
Distal anterior compartment myopathy: a dysferlin mutation causing a new muscular dystrophy phenotype. Ann Neurol (2001) 2.05
[Preventive treatment of nonrheumatic atrial fibrillation: from the efficacy of clinical trials to the effectiveness of clinical practice]. Aten Primaria (1997) 2.04
XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results. Br J Cancer (2011) 1.90
Radiation exposure to medical staff in interventional and cardiac radiology. Br J Radiol (1998) 1.87
Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways. Curr Med Chem (2003) 1.81
A pilot experience with permanent biventricular pacing to treat advanced heart failure. Am Heart J (2000) 1.78
Induced capacitance in the squid giant axon. Lipophilic ion displacement currents. J Gen Physiol (1983) 1.75
UGT1A1 gene variations and irinotecan treatment in patients with metastatic colorectal cancer. Br J Cancer (2004) 1.73
Programmed cell death in mature erythrocytes: a model for investigating death effector pathways operating in the absence of mitochondria. Cell Death Differ (2001) 1.69
Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector/senescent T cells. Mech Ageing Dev (2000) 1.68
Gynecomastia without lipodystrophy syndrome in HIV-infected men treated with efavirenz. AIDS (2001) 1.67
Factor VIII gene inversions in severe hemophilia A: results of an international consortium study. Blood (1995) 1.59
Regulation of exocytotic fusion by cell inflation. Biophys J (1998) 1.59
Pain in clinical oncology: patient satisfaction with management of cancer pain. Eur J Pain (2011) 1.51
A head-to-tail tandem organization of hsp70 genes in Trypanosoma cruzi. Nucleic Acids Res (1988) 1.47
Characteristics of intergenerational contractions of the CTG repeat in myotonic dystrophy. Am J Hum Genet (1994) 1.46
Parental origin and germline mosaicism of deletions and duplications of the dystrophin gene: a European study. Hum Genet (1992) 1.44
Failure of cefotaxime in the treatment of meningitis due to relatively resistant Streptococcus pneumoniae. Clin Infect Dis (1994) 1.44
[Rapidly-growing renal angiomyolipoma associated with pregnancy]. Actas Urol Esp (1994) 1.44
Indium-111-antimyosin scintigraphy after doxorubicin therapy in patients with advanced breast cancer. J Nucl Med (1990) 1.43
Radioimmune imaging of bone marrow in patients with suspected bone metastases from primary breast cancer. J Nucl Med (1990) 1.42
Cardiac output monitoring with pulmonary versus transpulmonary thermodilution during liver transplantation: interchangeable methods? Minerva Anestesiol (2014) 1.41
[Acquired neuromuscular syndrome in critically ill patients]. Rev Neurol (2006) 1.39
The use of latissimus dorsi muscle flap in reconstructive heart surgery. Plast Reconstr Surg (1994) 1.39
[Syndrome of the superior vena cava. (Compilation of the cases of the San Carlos University Clinical Hospital in Madrid in the last 5 years and review of the literature)]. An Med Interna (1995) 1.39
[Clinical manifestations of myotonic dystrophy: epidemiologic survey]. Med Clin (Barc) (1993) 1.38
Echocardiographic modeling of cardiac dyssynchrony before and during multisite stimulation: a prospective study. Pacing Clin Electrophysiol (2003) 1.38
Characterization of a non-long terminal repeat retrotransposon cDNA (L1Tc) from Trypanosoma cruzi: homology of the first ORF with the ape family of DNA repair enzymes. J Mol Biol (1995) 1.36
Progression of somatic CTG repeat length heterogeneity in the blood cells of myotonic dystrophy patients. Hum Mol Genet (1998) 1.36
The R71G BRCA1 is a founder Spanish mutation and leads to aberrant splicing of the transcript. Hum Mutat (2001) 1.36
3-Hydroxy-3-methylglutaryl coenzyme a reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture. Circ Res (1998) 1.31
Mutations in USH2A in Spanish patients with autosomal recessive retinitis pigmentosa: high prevalence and phenotypic variation. J Med Genet (2003) 1.31
Neovascularization in human atherosclerosis. Curr Mol Med (2006) 1.30
Immune and clinical parameters associated with Leishmania infantum infection in the golden hamster model. Vet Immunol Immunopathol (2000) 1.29
Identification of 14 novel mutations in the long isoform of USH2A in Spanish patients with Usher syndrome type II. J Med Genet (2006) 1.27
Metastatic colorectal cancer: integrating irinotecan into combination and sequential chemotherapy. Ann Oncol (2003) 1.26
Impact of CYP2D6 polymorphisms in tamoxifen adjuvant breast cancer treatment. Breast Cancer Res Treat (2009) 1.25
Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial. Br J Cancer (2006) 1.22
Prognostic influence of tumor-associated eosinophilic infiltrate in colorectal carcinoma. Cancer (2000) 1.21
Evolutionarily conserved proteins as prominent immunogens during Leishmania infections. Parasitol Today (2000) 1.21
BRCA in breast cancer: ESMO Clinical Practice Guidelines. Ann Oncol (2011) 1.20
Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy. Br J Cancer (2008) 1.19
Analysis of post-transcriptional regulation operating on transcription products of the tandemly linked Leishmania infantum hsp70 genes. J Biol Chem (1997) 1.19
Do non-long terminal repeat retrotransposons have nuclease activity? Trends Biochem Sci (1996) 1.17
The role of charged amphipathic helices in the structure and function of surfactant protein B. J Pept Res (2005) 1.16
A new locus for autosomal recessive retinitis pigmentosa (RP19) maps to 1p13-1p21. Genomics (1997) 1.16
A genotype-directed phase I-IV dose-finding study of irinotecan in combination with fluorouracil/leucovorin as first-line treatment in advanced colorectal cancer. Br J Cancer (2011) 1.15
Effect of chloroform on charge movement in the nerve membrane. Nature (1982) 1.15
Genomic predictors of response to doxorubicin versus docetaxel in primary breast cancer. Breast Cancer Res Treat (2011) 1.15
Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression. J Proteome Res (2012) 1.14
Methylenetetrahydrofolate reductase gene polymorphisms: genomic predictors of clinical response to fluoropyrimidine-based chemotherapy? Cancer Chemother Pharmacol (2005) 1.13
Multicomponent chimeric antigen for serodiagnosis of canine visceral leishmaniasis. J Clin Microbiol (1998) 1.13
LACE-conditioned autologous stem cell transplantation for relapsed or refractory Hodgkin's lymphoma: treatment outcome and risk factor analysis in 67 patients from a single centre. Bone Marrow Transplant (2006) 1.12
The African swine fever virus proteins p54 and p30 are involved in two distinct steps of virus attachment and both contribute to the antibody-mediated protective immune response. Virology (1998) 1.11
African swine fever virus gene A179L, a viral homologue of bcl-2, protects cells from programmed cell death. Virology (1996) 1.10
Neutralizing antibodies to different proteins of African swine fever virus inhibit both virus attachment and internalization. J Virol (1996) 1.10
Somatic instability of the myotonic dystrophy (CTG)n repeat during human fetal development. Hum Mol Genet (1997) 1.10
Clinical and genetic studies in Spanish patients with Usher syndrome type II: description of new mutations and evidence for a lack of genotype--phenotype correlation. Clin Genet (2005) 1.09
Meiotic drive at the myotonic dystrophy locus. J Med Genet (1994) 1.08
Genomic organization and expression of two independent gene arrays coding for two antigenic acidic ribosomal proteins of Leishmania. J Biol Chem (1993) 1.08
In situ hybridization of nuclear and cytoplasmic RNA to locus 2-48BC in Drosophila hydei. Chromosoma (1978) 1.08
Mutation profile of the MYO7A gene in Spanish patients with Usher syndrome type I. Hum Mutat (2006) 1.07
Immunostimulatory properties of the Leishmania infantum heat shock proteins HSP70 and HSP83. Mol Immunol (1999) 1.07
Comparison of CTG repeat length expansion and clinical progression of myotonic dystrophy over a five year period. J Med Genet (1995) 1.07
Molecular heterogeneity of myophosphorylase deficiency (McArdle's disease): a genotype-phenotype correlation study. Ann Neurol (2001) 1.06
Characterization of the immunostimulatory properties of Leishmania infantum HSP70 by fusion to the Escherichia coli maltose-binding protein in normal and nu/nu BALB/c mice. Infect Immun (1998) 1.06
Optimization and validation of recombinant serological tests for African Swine Fever diagnosis based on detection of the p30 protein produced in Trichoplusia ni larvae. J Clin Microbiol (2006) 1.06
Characterization and molecular basis of heterogeneity of the African swine fever virus envelope protein p54. J Virol (1994) 1.06
Effect of okadaic acid on O-linked N-acetylglucosamine levels in a neuroblastoma cell line. Biochim Biophys Acta (1999) 1.06
MYO7A mutation screening in Usher syndrome type I patients from diverse origins. J Med Genet (2007) 1.05
Neuromesenchymal hamartoma of the small bowel. J Clin Gastroenterol (1990) 1.04
Study of the involvement of the RGR, CRPB1, and CRB1 genes in the pathogenesis of autosomal recessive retinitis pigmentosa. J Med Genet (2003) 1.04
Z-DNA in transcriptionally active chromosomes. Proc Natl Acad Sci U S A (1987) 1.03
Binuclear chloro-bridged palladated and platinated complexes derived from p-isopropylbenzaldehyde thiosemicarbazone with cytotoxicity against cisplatin resistant tumor cell lines. J Inorg Biochem (1998) 1.03
Recombinant leishmania antigens for serodiagnosis of visceral leishmaniasis. Clin Diagn Lab Immunol (2005) 1.03
Lipogenesis in vivo in maternal and foetal tissues during late gestation in the rat. Biochem J (1981) 1.03
Bevacizumab in combination with metronomic chemotherapy in patients with anthracycline- and taxane-refractory breast cancer. J Chemother (2008) 1.02
DNA immunization with Trypanosoma cruzi HSP70 fused to the KMP11 protein elicits a cytotoxic and humoral immune response against the antigen and leads to protection. Infect Immun (2001) 1.02
Evidence against involvement of recoverin in autosomal recessive retinitis pigmentosa in 42 Spanish families. Hum Genet (1995) 1.02
Chronic effects of a high-fat diet enriched with virgin olive oil and a low-fat diet enriched with alpha-linolenic acid on postprandial endothelial function in healthy men. Br J Nutr (2008) 1.02
Molecular comparison of delta beta-thalassemia and hereditary persistence of fetal hemoglobin DNAs: evidence of a regulatory area? Proc Natl Acad Sci U S A (1982) 1.02
Identification of a putative regulatory element in the 3'-untranslated region that controls expression of HSP70 in Leishmania infantum. Mol Biochem Parasitol (2000) 1.02
A haplotype containing the p53 polymorphisms Ins16bp and Arg72Pro modifies cancer risk in BRCA2 mutation carriers. Hum Mutat (2006) 1.02